Bulk Drug Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Bulk Drug Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type (Antibiotics, Sulpha Drugs, Vitamins, Steroids, Analgesics, Others), By End-User (Pharmaceuticals, Biotechnology, Veterinary Medicine), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The global bulk drug market, encompassing Active Pharmaceutical Ingredients (APIs), is projected for substantial growth, expanding from USD 465.12 billion in 2025 to USD 925.96 billion by 2031 with a 12.16% CAGR. This expansion is fundamentally driven by the increasing global prevalence of chronic diseases, requiring long-term medication therapies, and the expiration of blockbuster drug patents, which fuels generic manufacturing. For example, India's bulk drug and drug intermediate exports reached USD 4.87 billion in fiscal year 2024-25, highlighting the sector's significant trade volume and industrial scale.
Market Driver
A primary catalyst for the bulk drug market is the surge in generic drug production following major patent expirations, creating immense demand for Active Pharmaceutical Ingredients (APIs) to meet the output of cost-effective alternatives. Healthcare systems further amplify this trend by promoting low-cost options to manage expenditures, with generic and biosimilar medicines comprising 90% of US prescriptions in 2024, as per the Association for Accessible Medicines, and the U.S. FDA approving 956 Abbreviated New Drug Applications in the prior year. Additionally, government incentives are critically reshaping the industry by strengthening domestic API supply chains, with nations reducing reliance on concentrated regions through subsidies for local manufacturing to foster self-reliance in Key Starting Materials. India's Production Linked Incentive scheme, for instance, has realized an investment of INR 4,155.77 crores, ensuring greater stability in raw material availability and protecting against geopolitical disruptions.
Market Challenge
A critical barrier to the bulk drug market's sustainable growth is its inherent supply chain volatility and significant dependence on concentrated geographical regions for raw materials. This logistical reliance creates a fragile operating environment, leaving manufacturers highly susceptible to external shocks like geopolitical tensions or economic instability, which lead to unpredictable production delays and escalating procurement costs, eroding profit margins and destabilizing production schedules. This uncertainty deters long-term capital investment and redirects resources from capacity expansion to crisis management. The substantial import volume, evidenced by India's USD 4.65 billion in bulk drug and intermediate imports for fiscal year 2024-25, highlights a lack of self-sufficiency, exposing the market to global supply chain fractures that impede consistent medication delivery and overall industry expansion.
Market Trends
Key trends reshaping the global bulk drug market include the growing adoption of Contract Development and Manufacturing Organization (CDMO) outsourcing, as pharmaceutical innovators increasingly partner with specialized providers to reduce capital expenditure and leverage advanced technical capabilities. This structural shift allows drug developers to concentrate on discovery and clinical research, mitigating risks associated with large-scale production facilities, and is reflected in the strong financial performance of CDMOs like Samsung Biologics, which reported a 23% revenue increase to KRW 4.55 trillion in 2024. Concurrently, the market is strategically pivoting towards complex generics, particularly peptides and oligonucleotides. These high-value Active Pharmaceutical Ingredients require specialized synthesis technologies and face lower competition due to significant entry barriers, offering superior profit margins. This focus on high-complexity molecules is driving rapid growth and intense technological innovation, exemplified by WuXi AppTec's TIDES business, which saw a 70.1% revenue growth to RMB 5.8 billion in 2024, specializing in these advanced therapies.
Key Market Players
* Dr. Reddy's Laboratories Ltd.
* Bayer AG
* Merck KGaA
* Cambrex Corporation
* Teva Pharmaceutical Industries Ltd.
* Johnson & Johnson Service Inc.
* BASF SE
* Novartis AG
* Pfizer Inc
Report Scope
In this report, the Global Bulk Drug Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Bulk Drug Market, By Type
* Antibiotics
* Sulpha Drugs
* Vitamins
* Steroids
* Analgesics
* Others
# Bulk Drug Market, By End-User
* Pharmaceuticals
* Biotechnology
* Veterinary Medicine
# Bulk Drug Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Bulk Drug Market.
Available Customizations:
Global Bulk Drug Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Bulk Drug Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Antibiotics, Sulpha Drugs, Vitamins, Steroids, Analgesics, Others)
5.2.2. By End-User (Pharmaceuticals, Biotechnology, Veterinary Medicine)
5.2.3. By Region
5.2.4. By Company (2025)
5.3. Market Map
6. North America Bulk Drug Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By End-User
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Bulk Drug Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By End-User
6.3.2. Canada Bulk Drug Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By End-User
6.3.3. Mexico Bulk Drug Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By End-User
7. Europe Bulk Drug Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By End-User
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Bulk Drug Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By End-User
7.3.2. France Bulk Drug Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By End-User
7.3.3. United Kingdom Bulk Drug Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By End-User
7.3.4. Italy Bulk Drug Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By End-User
7.3.5. Spain Bulk Drug Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By End-User
8. Asia Pacific Bulk Drug Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By End-User
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Bulk Drug Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By End-User
8.3.2. India Bulk Drug Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By End-User
8.3.3. Japan Bulk Drug Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By End-User
8.3.4. South Korea Bulk Drug Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By End-User
8.3.5. Australia Bulk Drug Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By End-User
9. Middle East & Africa Bulk Drug Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By End-User
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Bulk Drug Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By End-User
9.3.2. UAE Bulk Drug Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By End-User
9.3.3. South Africa Bulk Drug Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By End-User
10. South America Bulk Drug Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By End-User
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Bulk Drug Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By End-User
10.3.2. Colombia Bulk Drug Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By End-User
10.3.3. Argentina Bulk Drug Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Bulk Drug Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Dr. Reddy's Laboratories Ltd.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Bayer AG
15.3. Merck KGaA
15.4. Cambrex Corporation
15.5. Teva Pharmaceutical Industries Ltd.
15.6. Johnson & Johnson Service Inc.
15.7. BASF SE
15.8. Novartis AG
15.9. Pfizer Inc
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們